First Time Loading...

Takeda Pharmaceutical Co Ltd
TSE:4502

Watchlist Manager
Takeda Pharmaceutical Co Ltd Logo
Takeda Pharmaceutical Co Ltd
TSE:4502
Watchlist
Price: 4 089 JPY 0.79% Market Closed
Updated: Apr 19, 2024
Section:
 

Relative Value

The Relative Value of one Takeda Pharmaceutical Co Ltd stock under the Base Case scenario is 6 063.36 JPY. Compared to the current market price of 4 089 JPY, Takeda Pharmaceutical Co Ltd is Undervalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
6 063.36 JPY
Undervaluation 33%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.5
P/S
P/S
Price to Sales
1.5
vs History
80
vs Industry
61
Median 3Y
1.6
Median 5Y
1.6
Industry
2.4
Forward
1.6
More Details
36
P/E
P/E
Price to Earnings
36
vs History
38
vs Industry
11
Median 3Y
23.2
Median 5Y
28.7
Industry
22.2
Forward
46.2
More Details
8.8
P/OCF
P/OCF
Price to OCF
8.8
vs History
22
vs Industry
38
Median 3Y
5.8
Median 5Y
6.9
Industry
16.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
2
Median 3Y
-17.4
Median 5Y
1.5
Industry
22.4
More Details
1
P/B
P/B
Price to Book Value
1
vs History
71
vs Industry
62
Median 3Y
1
Median 5Y
1
Industry
2.1
More Details
2.5
EV/S
EV/S
Enterprise Value to Sales
2.5
vs History
74
vs Industry
44
Median 3Y
2.6
Median 5Y
2.6
Industry
2.6
Forward
2.5
More Details
3.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.7
vs History
71
vs Industry
52
Median 3Y
3.7
Median 5Y
3.8
Industry
5.1
More Details
8.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8.9
vs History
65
vs Industry
36
Median 3Y
8.9
Median 5Y
9.5
Industry
13.6
Forward
9.9
More Details
22.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.4
vs History
58
vs Industry
19
Median 3Y
21.1
Median 5Y
23.5
Industry
16.9
Forward
0
More Details
14.2
EV/OCF
EV/OCF
Enterprise Value to OCF
14.2
vs History
23
vs Industry
29
Median 3Y
9
Median 5Y
11.1
Industry
15.8
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
7
Median 3Y
11.5
Median 5Y
14.9
Industry
17.6
More Details
0.8
EV/IC
EV/IC
Enterprise Value to IC
0.8
vs History
39
vs Industry
65
Median 3Y
0.8
Median 5Y
0.8
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Takeda Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Takeda Pharmaceutical Co Ltd
TSE:4502
6.4T JPY 1.5 36 8.9 22.4
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
708.2B USD 20.8 135.1 61 70.1
DK
Novo Nordisk A/S
CSE:NOVO B
3.8T DKK 16.6 46 33.6 36.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
350.8B USD 4.1 10 11.2 14.7
US
Merck & Co Inc
NYSE:MRK
317B USD 5.3 868.6 43.3 84.5
UK
AstraZeneca PLC
LSE:AZN
169.2B GBP 4.6 35.3 139 223
CH
Roche Holding AG
SIX:ROG
175.4B CHF 3 15.3 8.4 10
CH
Novartis AG
SIX:NOVN
172.8B CHF 4.1 12.8 9.3 15.4
US
Pfizer Inc
NYSE:PFE
143.4B USD 2.5 67.7 10.4 15.5

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 129,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.